Super-selective venous sampling (S-SVS) with quick parathyroid hormone (PTH) assay for patients with persistent primary hyperparathyroidism

2019 ◽  
Vol 493 ◽  
pp. S333-S334
Author(s):  
S. Terzán-Molina ◽  
R. Pérez-Calleja ◽  
I. Miñambres-Donaire ◽  
R. Guerrero-Vara ◽  
A. Moral-Duarte ◽  
...  
2005 ◽  
Vol 71 (7) ◽  
pp. 557-563 ◽  
Author(s):  
Carmen C. Solorzano ◽  
Theresa M. Lee ◽  
Marcela C. Ramirez ◽  
Denise M. Carneiro ◽  
George L. Irvin

With a secure diagnosis of hyperparathyroidism, preoperative localization of abnormal glands is the initial step toward limited parathyroidectomy (LPX). We investigated whether ultrasonography in the hands of the surgeon (SUS) could improve the localization of abnormal parathyroids when sestamibi scans (MIBI) were negative or equivocal. One hundred eighty patients with sporadic primary hyperparathyroidism (SPHPT) underwent preoperative SUS and MIBI scans before LPX guided by intraoperative parathormone assay. When the sestamibi scans were negative, SUS was used to localize the parathyroid, distinguish parathyroid from thyroid tissue, and to guide the intraoperative jugular venous sampling for differential elevation of parathyroid hormone (PTH). Operative findings, intraoperative hormone dynamics, and postoperative calcium levels determined successful localization. MIBI was negative or equivocal in 36/180 (20%) patients: 1) showed no parathyroid gland in 22 patients, 2) suggested an incorrect location for the abnormal gland in 9, and 3) was insufficient in recognizing multiglandular disease in 5. In these 36 patients, the addition of SUS led to the successful identification of the abnormal tissue in 19/36 (53%). In the remaining 17 patients with negative/equivocal scans, the parathyroid could not be clearly visualized by SUS. In these patients, SUS facilitated LPX by aiding preoperative transcutaneous jugular venous sampling for differentially elevated PTH (n = 3) and identifying questionable thyroid nodule versus parathyroid tissue (n = 1). Overall, SUS was useful in 23/36 (67%) patients with nonlocalizing MIBI scans, thus improving the rate of localization from 80 per cent to 93 per cent ( P < 0.01). Surgeon-performed cervical ultrasonography improved the localization of abnormal parathyroids by MIBI scan, adding to the success of limited parathyroidectomy.


Surgery ◽  
2002 ◽  
Vol 132 (6) ◽  
pp. 944-951 ◽  
Author(s):  
Julia J. Jones ◽  
Laurent Brunaud ◽  
Christopher F. Dowd ◽  
Quan-Yang Duh ◽  
Eugene Morita ◽  
...  

2018 ◽  
Vol 7 (2) ◽  
pp. 205846011876036
Author(s):  
Masaya Ikuno ◽  
Takayuki Yamada ◽  
Yasumoto Shinjo ◽  
Tsuyoshi Morimoto ◽  
Reiko Kumano ◽  
...  

Background Selective venous sampling (SVS) is an invasive localization study for persistent or recurrent hyperparathyroidism. Purpose To assess the role of SVS in addition to non-invasive imaging for primary hyperparathyroidism (pHPT). Material and Methods This study was approved by the institutional review board and included 14 patients who underwent SVS and subsequent parathyroidectomy between January 2014 and April 2017 following a clinical diagnosis of pHPT. All patients underwent pre-SVS non-invasive imaging, including ultrasound, computed tomography (CT), and 99mTc-MIBI scintigraphy, and sensitivity was assessed using the operative and pathological findings. Results In all but one case, a single parathyroid adenoma was responsible for the pHPT; the remaining case exhibited a chemical response following surgical removal of parathyroid tissue. The sensitivity (%) for ultrasound, CT, 99mTc-MIBI scintigraphy, and SVS was 76.9, 84.6, 69.2, and 76.9, respectively. SVS yielded positive results in four patients with discordant results and one patient with non-detectable results on imaging. In seven patients, a significant increase in the intact parathyroid hormone level was recognized only in the thyroid veins. The procedure time was in the range of 52–183 min (median = 89.5 min). Conclusion The addition of SVS to a non-invasive imaging study would be helpful to locate the responsible lesion of pHPT with discordant or non-detectable results on imaging for initial surgical treatment as well.


2016 ◽  
Vol 40 (12) ◽  
pp. 2956-2963 ◽  
Author(s):  
Philip Y. Sun ◽  
Scott M. Thompson ◽  
James C. Andrews ◽  
Robert A. Wermers ◽  
Travis J. McKenzie ◽  
...  

2017 ◽  
Vol 35 (8) ◽  
pp. 409-416 ◽  
Author(s):  
Takayuki Yamada ◽  
Masaya Ikuno ◽  
Yasumoto Shinjo ◽  
Atsushi Hiroishi ◽  
Shoichiro Matsushita ◽  
...  

Surgery Today ◽  
2012 ◽  
Vol 42 (6) ◽  
pp. 570-576 ◽  
Author(s):  
Oliver Gimm ◽  
Lars-Gunnar Arnesson ◽  
Pia Olofsson ◽  
Olallo Morales ◽  
Claes Juhlin

Sign in / Sign up

Export Citation Format

Share Document